| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 427.99M | 558.06M | 345.85M | 213.38M | 207.14M | 250.89M |
| Gross Profit | 17.95M | 39.91M | 20.74M | 15.09M | 24.16M | -30.37M |
| EBITDA | -7.13M | -21.82M | -15.36M | -33.45M | -32.76M | -43.02M |
| Net Income | -16.11M | -23.81M | -21.60M | -88.39M | -100.83M | -55.46M |
Balance Sheet | ||||||
| Total Assets | 508.85M | 412.06M | 259.39M | 331.27M | 461.17M | 536.19M |
| Cash, Cash Equivalents and Short-Term Investments | 136.51M | 42.23M | 46.55M | 4.45M | 20.91M | 33.69M |
| Total Debt | 36.47M | 25.02M | 6.99M | 9.55M | 16.46M | 80.95M |
| Total Liabilities | 407.40M | 306.91M | 154.98M | 235.94M | 265.66M | 241.35M |
| Stockholders Equity | 110.34M | 113.60M | 111.51M | 101.56M | 198.54M | 295.58M |
Cash Flow | ||||||
| Free Cash Flow | -43.97M | -20.53M | 265.00K | 7.73M | 15.17M | -90.69M |
| Operating Cash Flow | -43.94M | -20.50M | 265.00K | 7.78M | 15.68M | -90.32M |
| Investing Cash Flow | 1.04M | 184.00K | 73.00K | -1.21M | 21.58M | 41.37M |
| Financing Cash Flow | 1.27M | 17.38M | 42.47M | -22.49M | -34.05M | 76.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | HK$385.35M | 1.21 | 11.37% | ― | 20.41% | 188.08% | |
64 Neutral | HK$150.37M | 3.77 | 8.56% | 23.73% | -32.31% | -51.89% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | HK$112.57M | 2.55 | 2.70% | ― | -27.58% | -18.28% | |
57 Neutral | HK$416.63M | -11.76 | -16.46% | ― | 50.20% | 15.20% | |
51 Neutral | HK$21.36B | 659.69 | 1.30% | ― | 78.48% | -33.33% | |
49 Neutral | HK$126.41M | -36.13 | -0.68% | 7.69% | -33.92% | -94.74% |
CT Vision (International) Holdings Limited has issued a clarification stating that the exercise price for share options recently granted is HK$0.351 per share, correcting a previously stated figure of HK$0.35 that arose from a rounding error. The company emphasized that the corrected price complies with listing rules by matching the highest of the offer-date closing price, the five-day average closing price, and the nominal share value, and that no other terms of the option grant or prior disclosures are affected, signalling that the adjustment is purely technical with no broader change to its share option scheme or governance arrangements.
The most recent analyst rating on (HK:0994) stock is a Hold with a HK$0.35 price target. To see the full list of analyst forecasts on CT Vision S.L. (International) Holdings Limited stock, see the HK:0994 Stock Forecast page.
CT Vision (International) Holdings Limited has granted 50 million share options to five grantees under its existing share option scheme adopted in June 2017, with each option entitling the holder to subscribe for one ordinary share of HK$0.01 par value. The options, offered on 29 January 2026 with an exercise price of HK$0.35 per share and a validity period running until 28 January 2036, are priced at the highest of the recent market benchmarks, signalling a structured long-term incentive intended to align the interests of key participants with shareholders and potentially support the company’s long-term share performance and talent retention.
The most recent analyst rating on (HK:0994) stock is a Hold with a HK$0.37 price target. To see the full list of analyst forecasts on CT Vision S.L. (International) Holdings Limited stock, see the HK:0994 Stock Forecast page.
CT Vision (International) Holdings Limited, a company listed on the Hong Kong Stock Exchange, announced a major change in its shareholding structure after its controlling shareholder, CT Vision Investment Limited, significantly reduced its direct stake while maintaining overall control through a concert-party arrangement.
CT Vision Investment has sold a total of 293.32 million shares, or 26.4% of the company’s issued share capital, in two separate transactions: 12% to an independent third party and 14.4% to a corporation controlled by one of its existing shareholders. Following completion, CT Vision Investment’s direct holding fell from 53.93% to 27.53%, but it and Purchaser 2 are together deemed controlling shareholders under Hong Kong securities law as they jointly hold more than 30% of the company’s voting rights. Both Purchaser 1 and Purchaser 2 have become substantial shareholders, signalling a diversification of the shareholder base while preserving effective control within the existing investor group.
The most recent analyst rating on (HK:0994) stock is a Hold with a HK$0.27 price target. To see the full list of analyst forecasts on CT Vision S.L. (International) Holdings Limited stock, see the HK:0994 Stock Forecast page.
CT Vision (International) Holdings Limited has announced the resignation of Mr. Fu Wing Kwok Ewing as financial controller, company secretary and authorised representative for regulatory purposes in Hong Kong, effective 2 January 2026, citing other career and personal pursuits, with the company emphasising that there is no disagreement between Mr. Fu and the board nor any issues requiring shareholder attention. To ensure continuity in its corporate governance and compliance functions, the board has appointed experienced accounting and company secretarial professional Mr. Leung Gavin L., currently the firm’s Human Resources and Administration Manager and a CPA Australia fellow, as company secretary and authorised representative from the same date, a move aimed at maintaining robust regulatory interface and internal control as the company navigates its listed-company obligations.
The most recent analyst rating on (HK:0994) stock is a Hold with a HK$0.27 price target. To see the full list of analyst forecasts on CT Vision S.L. (International) Holdings Limited stock, see the HK:0994 Stock Forecast page.
CT Vision (International) Holdings Limited, a company incorporated in the Cayman Islands, has announced a change in its company name and stock short names. The company has officially changed its English name from ‘CT Vision S.L. (International) Holdings Limited’ to ‘CT Vision (International) Holdings Limited’ and its Chinese name accordingly. The stock short names will also be updated on the Stock Exchange, effective from December 22, 2025. This change will not affect shareholders’ rights or the company’s daily operations, as existing share certificates remain valid.
The most recent analyst rating on (HK:0994) stock is a Hold with a HK$0.27 price target. To see the full list of analyst forecasts on CT Vision S.L. (International) Holdings Limited stock, see the HK:0994 Stock Forecast page.
CT Vision S.L. (International) Holdings Limited has completed a connected transaction involving the subscription of new shares under a specific mandate. The completion of the Second Subscription Agreement was announced, with 63,000,000 shares subscribed at HK$0.36 each. This transaction affects the company’s shareholding structure, with the Second Subscriber now holding approximately 5.67% of the shares, impacting the distribution among existing shareholders.
The most recent analyst rating on (HK:0994) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on CT Vision S.L. (International) Holdings Limited stock, see the HK:0994 Stock Forecast page.